Ligand Pharmaceuticals Inc (LGND)
Operating Cash Flow Growth
138.13%
TTM · Period ending:
LGND Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported138.13%period ending
Latest reported138.13%period ending
LGND TTM Cash from Operations YoY % (-2.10% → 138.13%)
Year-over-year change
High-resolution chart · PNG
LGND operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 27.3933% | |
| 10.9409% | |
| 21.7273% | |
| 27.5374% | |
| 33.4449% | |
| 23.5577% | |
| 9.1592% | |
| -80.0539% | |
| -144.1379% | |
| -170.751% | |
| -397.0149% | |
| -13.4557% | |
| 10.7692% | |
| 24.024% | |
| 59.7598% | |
| -3.8095% | |
| -33.1967% | |
| -68.1818% | |
| -128.0822% | |
| -37.5% | |
| -2.0979% |